Journal
MOLECULES
Volume 27, Issue 19, Pages -Publisher
MDPI
DOI: 10.3390/molecules27196224
Keywords
copper-containing amine oxidases; semicarbazide-sensitive amine oxidase; adipose tissue; hydrogen peroxide; insulin-like agents; obesity; diabetes; human adipocytes
Funding
- INSERM, France
- Semmelweis University, Hungary
Ask authors/readers for more resources
Benzylamine, a natural molecule found in food and edible plants, has been found to activate hexose uptake and inhibit lipolysis in human fat cells. These effects rely on the oxidation of benzylamine by amine oxidases in adipocytes, leading to the production of hydrogen peroxide, which exhibits insulin-like actions. The study identified compounds that interact with highly expressed amine oxidases in human adipocytes and showed that they have similar metabolic effects to benzylamine, making them potential candidates for the treatment of obesity and diabetes.
Benzylamine is a natural molecule present in food and edible plants, capable of activating hexose uptake and inhibiting lipolysis in human fat cells. These effects are dependent on its oxidation by amine oxidases present in adipocytes, and on the subsequent hydrogen peroxide production, known to exhibit insulin-like actions. Virtually, other substrates interacting with such hydrogen peroxide-releasing enzymes potentially can modulate lipid accumulation in adipose tissue. Inhibition of such enzymes has also been reported to influence lipid deposition. We have therefore studied in human adipocytes the lipolytic and lipogenic activities of pharmacological entities designed to interact with amine oxidases highly expressed in this cell type: the semicarbazide-sensitive amine oxidase (SSAO also known as PrAO or VAP-1) and the monoamine oxidases (MAO). The results showed that SZV-2016 and SZV-2017 behaved as better substrates than benzylamine, releasing hydrogen peroxide once oxidized, and reproduced or even exceeded its insulin-like metabolic effects in fat cells. Additionally, several novel SSAO inhibitors, such as SZV-2007 and SZV-1398, have been evidenced and shown to inhibit benzylamine metabolic actions. Taken as a whole, our findings reinforce the list of molecules that influence the regulation of triacylglycerol assembly/breakdown, at least in vitro in human adipocytes. The novel compounds deserve deeper investigation of their mechanisms of interaction with SSAO or MAO, and constitute potential candidates for therapeutic use in obesity and diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available